Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
Phase 1/2 Completed
24 enrolled 16 charts
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
Phase 2 Completed
74 enrolled 33 charts
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
Phase 1 Completed
3 enrolled
Evaluation, Treatment, and Training for Patients With Blood Disorders
Completed
1,452 enrolled
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
Phase 3 Completed
14 enrolled
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
Phase 2 Completed
8 enrolled 6 charts
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Phase 4 Completed
45 enrolled
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
Phase 2 Completed
16 enrolled 11 charts
Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
Phase 2 Completed
44 enrolled 13 charts
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
Phase NA Completed
447 enrolled
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
Phase 2 Completed
45 enrolled 12 charts
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
Phase 3 Completed
97 enrolled
Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors
Phase NA Completed
315 enrolled
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
Phase 2 Completed
239 enrolled 23 charts
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Phase 3 Completed
365 enrolled
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Phase 3 Completed
344 enrolled
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
Phase 2 Completed
30 enrolled
B-Receptor Signaling in Cardiomyopathy
Completed
99 enrolled
Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 1 Completed
39 enrolled
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
Phase NA Completed
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
Phase 3 Completed
275 enrolled
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
Phase 2 Completed
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
Phase 2 Completed
A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy
Phase 3 Completed
224 enrolled
Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia
Phase 2 Completed
195 enrolled
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
Phase 3 Completed
502 enrolled 30 charts
Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.
Phase 3 Completed
66 enrolled
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
Phase 1 Completed
25 enrolled